Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Blog
Blog
Share
Blog
Jul 23, 2018
| Rachel Schwartz
Ariel is a Cancer Thriver
Blog
Jun 28, 2018
| Rachel Schwartz
2018 Generic Drug Access and Savings Report
Blog
Jun 20, 2018
| Craig Burton
Why Seniors Are Paying More as Drug Prices Fall
Blog
Jun 6, 2018
| Jeff Watson
Pass the CREATES Act to End Manipulative Practices That Cost Our Patients Billions
Blog
May 29, 2018
| Rachel Schwartz
AAM Speaks on Involvement in the Prescription Drug Safety Network
Blog
May 22, 2018
| Erica Klinger
Gold and Platinum Hermes Awards for AAM
Blog
May 14, 2018
| Jeff Francer
AAM’s Comments on USTR’s Proposed China Tariffs
Blog
May 14, 2018
| Jennifer Soup
Reinventing AAM’s Meetings
Blog
May 10, 2018
| David Gaugh
FDA Approvals: Good News for Patients, More Work to Do (Part 2)
Blog
May 10, 2018
| Chip Davis
Dear Mr. President—On the Eve of Your Drug-Pricing Speech
Blog
May 9, 2018
| David Gaugh
FDA Approvals: Good News for Patients, More Work to Do (Part 1)
Blog
May 3, 2018
| Christine Simmon
The Biosimilars Council Congressional Briefing: Five Takeaways
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action